Transcripta Bio Secures $24M to Pioneer Transcriptome-Based Drug Discovery
In the high-stakes arena of modern pharmaceutical research, where the attrition rate for new drug candidates often exceeds 90%, a...
In the high-stakes arena of modern pharmaceutical research, where the attrition rate for new drug candidates often exceeds 90%, a...
In a significant move that bridges the gap between extracellular matrix (ECM) biology and advanced bioconjugation chemistry, Lonza and Engitix...
In a somber turn of events for the biotechnology sector, Sangamo Therapeutics—a Bay Area-based company that effectively birthed the field...
FOR IMMEDIATE RELEASE Cambridge, UK – – In an era defined by rapid technological obsolescence, the preservation of computing history...